Magnetic bead-mannose combined lectin compound as well as construction method and application thereof
The microbial enrichment of respiratory samples through magnetic bead-mannose-binding lectin complex solves the problem of human genomic noise interference in high-throughput sequencing, and improves the quality of microbiome data and the accuracy of sequencing results.
Patent Information
- Application Number
- CN202310632850.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-31
- Publication Date
- 2024-12-03
AI Technical Summary
In high-throughput sequencing, the acquisition and analysis of respiratory microbiome data is disturbed by human genome noise, which leads to difficulties in interpreting microbial population composition and function. The existing technology's treatment of host cells before microbial nucleic acid extraction has a relatively stable condition for some microorganisms Low, making it difficult to effectively reduce the host background noise in the sequencing data.
The magnetic bead-mannose binding lectin complex was used to connect through the -(CH2)3CHOHCH2NH-group, and the DynabeadsTMM-270Epoxy epoxy resin magnetic beads were covalently coupled with the mannose binding lectin to construct the microorganisms for respiratory samples. Enrichment method reduces host cells and nucleic acids and improves microbiome data abundance.
It significantly improves the abundance of sequencing data of respiratory microorganisms, reduces the impact of host background, and increases the proportion of microbial gene fragments and gene loci coverage by metagenomic sequencing, which helps to monitor the spread of drug-resistant bacteria and virulence genes in real time.
Smart Images

Figure CN119060195A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biomedicine, and in particular to a magnetic bead-mannose binding lectin complex, a construction method and an application thereof. Background Art
[0002] High-throughput sequencing technology can provide genomic information of pathogens, which helps to understand the biological characteristics of pathogens from multiple dimensions such as pathogenicity, drug resistance, and evolutionary variation. Clinical metagenomics, which was developed from high-throughput sequencing technology, has been applied to the field of clinical microbial diagnosis in the past 10 years. High-throughput sequencing combined with other omics technologies can simultaneously analyze the dynamic changes of the bacterial group, viral group, transcriptome, proteome, and metabolome, revealing how symbiotic microorganisms and their metabolites affect the local microecological composition, immune response, and biochemical reaction processes.
[0003] When analyzing the human microbiome, especially samples with low microbial content such as the respiratory tract, the length of the human genome (3×10 9 bases) is approximately the average length of a bacterial genome (3×10 6 When performing metagenomic sequencing, a large amount of data comes from the genes of human cells, which becomes background noise for the acquisition and analysis of microbiome data, interfering with the interpretation of the composition and function of microbial populations. Although the amount of microbiome data can be increased to a certain extent by increasing the sequencing depth, this strategy will increase sequencing costs and data analysis time, and place high demands on the computer's analysis performance.
[0004] At present, the main technical difficulty in the clinical application of metagenomic sequencing is how to reduce the host background effect in the sequencing results and increase the abundance of microbial sequencing data. Enriching the microorganisms in the sample before sequencing to reduce host cells and nucleic acids can increase the microbiome data information and help to better reveal the composition and function of microorganisms. At present, metagenomic sequencing studies mostly adopt the strategy of pre-lyzing host cells before microbial nucleic acid extraction and using nucleases or propidium monoazide (PMA) to degrade host nucleic acids to reduce host background noise in sequencing data. Although the differences in biological properties between human cells and microorganisms can be used to remove host nucleic acids based on principles such as osmotic pressure and saponin, some studies have shown that protists, bacteria without cell walls, Gram-positive bacteria and enveloped viruses are relatively less stable to this treatment method, and the loss of nucleic acid fragments of Streptococcus pneumoniae and influenza A virus may occur during centrifugation, washing and nuclease digestion [see: Hasan, MR, A. Rawat, P. Tang, et al., Depletion of Human DNA in Spiked Clinical Specimens for Improvement of Sensitivity of Pathogen Detection by Next-Generation Sequencing. J Clin Microbiol, 2016. 54(4): p. 919-27.].
[0005] Therefore, how to enrich the microorganisms in respiratory samples to reduce host cells and nucleic acids before sequencing the respiratory microorganisms is a key issue. Summary of the invention
[0006] In view of this, the purpose of the present invention is to propose a magnetic bead-mannose binding lectin complex, a construction method and its application, which has a high enrichment efficiency for microorganisms in respiratory samples, thereby reducing the host background effect in the sequencing results and improving the sequencing data abundance of respiratory microorganisms.
[0007] Based on the above objectives, the first aspect of the present invention provides a magnetic bead-mannose binding lectin complex, wherein the magnetic bead and the mannose binding lectin are connected via a -(CH2)3CHOHCH2NH- group.
[0008] In a preferred embodiment of the present invention, the magnetic beads are epoxy resin magnetic beads;
[0009] Preferably, the magnetic beads are Dynabeads TM M-270Epoxy epoxy resin magnetic beads.
[0010] The second aspect of the present invention provides a method for constructing a magnetic bead-mannose binding lectin complex, wherein the magnetic beads and the mannose binding lectin are mixed and then incubated.
[0011] In a preferred embodiment of the present invention, an ammonium sulfate solution and a mannose-binding lectin protein solution are added to a suspension of magnetic beads, mixed, and then incubated;
[0012] Preferably, the concentration of the ammonium sulfate solution is 1-3 mol / L; the ammonium sulfate solution serves as a buffer for the coupling reaction between the epoxy groups carried on the surface of the magnetic beads and the primary amino groups of the mannose binding lectin, providing a suitable pH value and salt ion strength for the coupling process between the magnetic beads and the mannose binding lectin; more preferably, the concentration of the ammonium sulfate solution is 3 mol / L;
[0013] Preferably, the magnetic beads and mannose binding lectin are mixed at a rate of (2-5)×10 8 Mixed at a ratio of magnetic beads / 100 μg mannose-binding lectin;
[0014] More preferably, the magnetic beads and the mannose-binding lectin are mixed at a rate of (3-4)×10 8 Mixed at a ratio of magnetic beads / 100 μg mannose-binding lectin;
[0015] And / or, the incubation is at 30-40° C. for 18-30 h;
[0016] Preferably, the incubation is at 35-38°C for 22-26 hours;
[0017] More preferably, the incubation is incubation in a rotary culture mixer;
[0018] And / or, the magnetic beads are epoxy resin magnetic beads;
[0019] Preferably, the magnetic beads are Dynabeads TM M-270Epoxy epoxy resin magnetic beads.
[0020] A third aspect of the present invention provides a method for enriching microorganisms in a respiratory sample, comprising the following steps:
[0021] 1) mixing the respiratory sample with the magnetic beads-mannose binding lectin complex and incubating;
[0022] 2) eluting the microorganisms enriched on the surface of the magnetic bead-mannose binding lectin complex to obtain enriched respiratory samples.
[0023] In a preferred embodiment of the present invention, the respiratory sample is a freshly collected throat swab.
[0024] In a preferred embodiment of the present invention, the incubation is at 30-40° C. for 0.5-2 h;
[0025] Preferably, the incubation is at 35-38°C for 0.7-1.5h;
[0026] The incubation is carried out in a rotary culture mixer;
[0027] And / or, the elution process is: first wash the magnetic bead-mannose binding lectin complex with PBS buffer under sterile conditions, wash 2 to 5 times, and then wash the magnetic bead-mannose binding lectin complex with 0.05 to 0.2 M citrate solution.
[0028] A fourth aspect of the present invention provides a method for performing metagenomic sequencing on a respiratory sample, comprising the following steps:
[0029] 1) mixing the respiratory sample with the magnetic beads-mannose binding lectin complex and incubating;
[0030] 2) eluting the microorganisms enriched on the surface of the magnetic bead-mannose binding lectin complex to obtain enriched respiratory samples;
[0031] 3) Extracting DNA from enriched respiratory samples;
[0032] 4) Construct an Illumina sequencing library and perform metagenomic sequencing.
[0033] In a preferred embodiment of the present invention, the respiratory sample is a freshly collected throat swab.
[0034] In a preferred embodiment of the present invention, the process of extracting DNA from the enriched respiratory sample is: first, ZR BashingBead is added to the enriched respiratory sample to lyse the bacterial cell wall, and then DNA is extracted from the lysed sample using the miniMAG magnetic bead method;
[0035] And / or, construct Illumina sequencing libraries using TruePrep Flexible DNA Library Prep Kit for Illumina.
[0036] The beneficial effects of the present invention are:
[0037] (1) The magnetic bead-mannose binding lectin complex of the present invention has a high enrichment efficiency for respiratory microorganisms in the host cell background.
[0038] (2) The present invention utilizes the epoxy groups carried on the surface of activated epoxy resin magnetic beads to directly covalently bind to the primary amino groups of mannose binding lectin, thereby realizing the rapid preparation of magnetic bead-mannose binding lectin complexes. This construction method does not require prior engineering of the MBL protein, and the preparation method is fast and simple.
[0039] (3) The present invention applies the constructed magnetic bead-mannose binding lectin complex to the enrichment of respiratory microorganisms, and for the first time combines it with high-throughput sequencing technology. Experiments show that the method of enriching respiratory microorganisms using the constructed magnetic bead-mannose binding lectin complex can increase the proportion of respiratory microorganism gene fragments in metagenomic sequencing data and significantly increase the richness of microorganisms in the sample; the method of enriching respiratory microorganisms using the constructed magnetic bead-mannose binding lectin complex helps to improve the real-time monitoring of the prevalence of multidrug-resistant bacteria in the environment and the spread of drug resistance and virulence genes between bacteria by metagenomic sequencing, and sequencing after enrichment can increase the coverage of gene sites of extremely low-abundance microorganisms in throat swab samples, which helps to analyze related gene functions and mutations. BRIEF DESCRIPTION OF THE DRAWINGS
[0040] Figure 1 This is the construction principle of MBL magnetic beads.
[0041] Figure 2 This is the result of detecting MBL protein coated with magnetic beads using the BCA protein quantification method.
[0042] Figure 3 These are the culture results of original samples, MBL magnetic bead enriched samples, and naked magnetic bead enriched samples of Staphylococcus aureus (A), Klebsiella pneumoniae (B), and Pseudomonas aeruginosa (C).
[0043] Figure 4 Statistics of the amount of sequencing data after quality control in samples before (Pre) and after (MBL) MBL magnetic bead enrichment.
[0044] Figure 5 The ratios of host (A) and microbial (B) fragments in samples before (Pre) and after (MBL) enrichment with MBL magnetic beads.
[0045] Figure 6 These are the results of quantitative analysis of the glyceraldehyde-3-phosphate dehydrogenase (GADPH) gene in samples before (Pre) and after (MBL) enrichment.
[0046] Figure 7 Statistical results of Chao1 index of microbiome between samples before (Pre) and after (MBL) enrichment.
[0047] Figure 8The principal coordinate analysis results of the microbiome samples of different volunteers before (Pre) and after (MBL) enrichment.
[0048] Fig. 9 It is the Bray-Curtis distance index between different samples of the same volunteer and samples of different volunteers.
[0049] Fig.10 Comparison of the number of drug-resistant genes in samples before (Pre) and after (MBL) enrichment (A), the detection of all drug-resistant genes in samples before (Pre) and after (MBL) enrichment (B), and the statistical results of drug-resistant genes with significantly increased detection numbers after enrichment (C).
[0050] Fig.11 Comparison of the number of bacterial virulence genes in samples before (Pre) and after (MBL) enrichment (A), statistics of the number of all virulence genes detected (B), and statistics of virulence genes with increased detection numbers in all samples after enrichment (C).
[0051] Fig.12 Statistics of genome coverage of Klebsiella pneumoniae and Bacteroides fragilis after sequencing of samples before (Pre) and after (MBL) enrichment.
[0052] Fig.13 It is the number of species-level MAGs (alignment length >= 25Kbp) within the samples before and after enrichment.
[0053] Fig.14 This is the statistics of the common microbial genome coverage after sample assembly before and after enrichment.
[0054] Fig.15 The number of genes annotated for the common microbial assembly after sample assembly before and after enrichment. DETAILED DESCRIPTION
[0055] It should be noted that, unless otherwise defined, the technical terms or scientific terms used in this application should have the common meanings understood by technicians in the relevant field.
[0056] The experimental methods in the following examples are conventional methods unless otherwise specified. The medicinal materials, reagents, etc. used in the following examples are commercially available products unless otherwise specified.
[0057] As used herein and in the appended claims, the singular forms "a," "an," "another," and "the" include plural referents unless the context clearly dictates otherwise.
[0058] Mannose-binding Lectin (MBL) is a C-type lectin synthesized and secreted by hepatocytes in the early stage of infection. It is composed of 228 amino acids. According to the structure, it is divided into a cysteine-rich region, a collagen-like region, a neck region, and a calcium-dependent carbohydrate recognition domain (CRD) from the amino terminus to the carboxyl terminus. In the acute phase, serum MBL undergoes conformational changes after binding to polysaccharide residues such as D-mannose, mannosamine, N-acetyl-D-glucosamine, and fucose on the surface of microorganisms such as bacteria, fungi, and viruses through CRD in a calcium ion environment, activating the MBL-related serine protease connected to it and initiating the lectin pathway of complement activation. Since the above-mentioned polysaccharide residues on the surface of vertebrate cells are covered with components such as sialic acid, MBL cannot bind to them. Taking advantage of the ability of MBL to distinguish between microorganisms and host cells, Kang et al. first proposed a nonspecific microbial capture method based on MBL in 2014. After removing the collagen-like domain with procoagulant activity, the Fc-containing Mannose-binding Lectin (Fc-MBL) fused to the Fc segment was coated on nanomagnetic beads. The blood of sepsis patients was then mixed with the Fc-MBL magnetic beads. The captured pathogens and toxins could be purified from the blood through separation technology and then returned to the patient's body [see: Kang, JH, M. Super, CW Yung, et al., An extracorporeal blood-cleansing device for sepsis therapy. Nat Med, 2014. 20(10): p. 1211-6.]. This extracorporeal blood purification device, known as the "biological spleen", can effectively remove a variety of bacteria including Staphylococcus aureus and Escherichia coli at a filtration rate of up to 1.25 L / h, thereby improving the survival rate after sepsis occurs. In addition to bacteria, Fc-MBL magnetic beads can also capture fungi such as Candida albicans in the blood [see: Chen, XL, H.Zheng, WGLi, et al., Direct Blood Culturing of Candida spp. on Solid Medium by a Rapid Enrichment Method with Magnetic Beads Coated with Recombinant Human Mannan-Binding Lectin. J Clin Microbiol, 2020.58(4).]. This enrichment method can significantly shorten the identification time of blood culture.Another study combined the use of Fc-MBL and IgG magnetic beads to overcome the interference of chemicals in blood samples and the enrichment bias of Fc-MBL magnetic beads alone, improving the accuracy of matrix-assisted laser desorption ionization time-of-flight mass spectrometry for microbial identification and shortening the identification time [see: Xue, Y., H. Shi, B. Feng, et al., Rapid identification of bacteria directly from blood cultures by Co-magnetic beadenrichment and MALDI-TOF MS profiling. Talanta, 2021. 233: p. 122472.]. In addition to blood samples, MBL-based enrichment methods have also been attempted to enrich microorganisms in cerebrospinal fluid, aqueous humor, and arthritis tissue samples [see: 1. Bicart-See, A., M. Rottman, M. Cartwright, et al., Rapid Isolation of Staphylococcus aureus Pathogens from Infected Clinical Samples Using Magnetic Beads Coated with Fc-Mannose Binding Lectin. PLoS One, 2016. 11(6): p. e0156287. 2. Yu, M., L. Zhang, G. Qian, et al., Fc-MBL-modified Fe3O4 magnetic bead enrichment and fixation in Gram stain for rapid detection of low-concentration bacteria. Mikrochim Acta, 2022. 189(4): p. 169. 3. Ren, J., M. Yu, W. Gao, et al., Rapid Pathogen Identification in Aqueous Humor Samples by CombiningFc-MBL@Fe(3)O(4)Enrichment and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Profiling. Microbiol Spectr, 2022.10(6):p.e0176722.].
[0059] Since the current MBL magnetic bead enrichment system is mostly used to improve the detection limit of blood-borne infection pathogens or the treatment of sepsis, it is necessary to use genetic engineering methods to remove the collagen-like domain with procoagulant activity in the MBL protein in advance. In the prior art, the MBL protein is usually first structurally modified to remove the collagen-like domain, and then fused with human IgG1 Fc. Fc-containing MBL (Fc-MBL) is biotinylated at its N-terminus by adding the tripeptide sequence alanine-lysine-threonine, and the specific biotinylation of the terminal tripeptide sequence allows Fc-MBL to bind to the magnetic beads. In other words, the prior art connects the engineered Fc-MBL to the magnetic beads through the tripeptide sequence alanine-lysine-threonine, and does not directly covalently bind the intact MBL protein to the magnetic beads.
[0060] The present application provides a magnetic bead-mannose binding lectin complex, wherein the magnetic bead and the mannose binding lectin are connected via a -(CH2)3CHOHCH2NH- group.
[0061] In a preferred embodiment of the present invention, the magnetic beads are epoxy resin magnetic beads;
[0062] Preferably, the magnetic beads are Dynabeads TM M-270Epoxy epoxy resin magnetic beads.
[0063] The second aspect of the present invention provides a method for constructing a magnetic bead-mannose binding lectin complex, wherein the magnetic beads and the mannose binding lectin are mixed and then incubated.
[0064] The mechanism of constructing the magnetic bead-mannose binding lectin complex of the present invention is as follows: the present invention utilizes Dynabeads TM The epoxy groups on the surface of M-270Epoxy resin magnetic beads can directly covalently bind to the primary amino groups on the surface of mannose-binding lectin through a ring-opening reaction to quickly construct a bead-mannose-binding lectin complex (such as Figure 1 shown).
[0065] Based on the physicochemical properties of MBL, the present invention combines magnetic separation technology to construct a magnetic bead-mannose binding lectin complex that is independent of MBL structural modification. Since the procoagulant activity of the collagen-like domain in the MBL protein has little effect on respiratory samples, this method does not require engineering modification of the MBL protein in advance, and the preparation method is fast and simple.
[0066] In addition, there is currently limited research on the application effect of this enrichment system in respiratory samples with differences in physical properties, chemical composition and host cell ratio. The present invention applies this method to the enrichment of respiratory microorganisms. The present invention establishes a non-specific positive enrichment method for microorganisms in respiratory samples based on magnetic separation technology. Therefore, the present invention also provides a method for enriching microorganisms in respiratory samples, which comprises the following steps:
[0067] 1) mixing the respiratory sample with the magnetic beads-mannose binding lectin complex and incubating;
[0068] 2) eluting the microorganisms enriched on the surface of the magnetic bead-mannose binding lectin complex to obtain enriched respiratory samples.
[0069] The present invention selects mannose binding lectin that can non-specifically bind to the sugar group on the surface of microorganisms as a coupling carrier of epoxy resin immunomagnetic beads to construct a magnetic bead-mannose binding lectin complex. The constructed magnetic bead-mannose binding lectin complex is applied to the enrichment of respiratory microorganisms. This method belongs to a non-specific positive enrichment method, which is generally designed for the common characteristics of most microorganisms. The corresponding enrichment scheme. Among them, non-specific means that the method can enrich a variety of microorganisms in respiratory samples, rather than being limited to a specific microorganism, and positive means that the method directly captures the desired respiratory microorganisms without pre-lyzing the host cells.
[0070] The prior art does not report the combined application of the enrichment system and high-throughput sequencing technology. The present invention combines the enrichment system with high-throughput sequencing technology for the first time to reveal the characteristics of airway microbial composition. Therefore, the present invention provides a method for performing metagenomic sequencing after enrichment of respiratory sample microorganisms, which comprises the following steps:
[0071] 1) mixing a respiratory sample with the magnetic bead-mannose binding lectin complex of claim 1 or 2, and incubating the mixture;
[0072] 2) eluting the microorganisms enriched on the surface of the magnetic bead-mannose binding lectin complex to obtain enriched respiratory samples;
[0073] 3) Extracting DNA from enriched respiratory samples;
[0074] 4) Construct an Illumina sequencing library and perform metagenomic sequencing.
[0075] The present invention evaluates the application effect of the MBL magnetic bead enrichment method in high-throughput sequencing by analyzing indicators such as the proportion of microbial gene fragments and microbial diversity in metagenomic sequencing data. The specific scheme is: in the early stage, common respiratory pathogens are mixed with a certain number of host cells to prepare simulated respiratory infection samples, and the enrichment efficiency of MBL magnetic beads for pathogens of different respiratory infection patterns is evaluated. Throat swabs of healthy volunteers are collected, and the constructed MBL magnetic beads are used to enrich the test sample microorganisms. The effect of the enrichment method is verified by metagenomic sequencing technology, including changes in key microbiome indicators such as the proportion of microbial gene fragments, α and β diversity, and the detection of bacterial resistance and virulence genes.
[0076] The results show that the magnetic bead-mannose binding lectin complex of the present invention has a high enrichment efficiency for respiratory microorganisms in the host cell background. The present invention applies the constructed magnetic bead-mannose binding lectin complex to the enrichment of respiratory microorganisms, and combines it with high-throughput sequencing technology for the first time. Experiments show that the method of enriching respiratory microorganisms using the constructed magnetic bead-mannose binding lectin complex can increase the proportion of respiratory microbial gene fragments in metagenomic sequencing data and significantly improve the richness of microorganisms in the sample; the method of enriching respiratory microorganisms using the constructed magnetic bead-mannose binding lectin complex helps to improve the real-time monitoring of the prevalence of multidrug-resistant bacteria in the environment and the spread of resistance and virulence genes between bacteria by metagenomic sequencing, and sequencing after enrichment can improve the coverage of genomic sites of extremely low-abundance microorganisms in throat swab samples, which is helpful for the analysis of related gene functions and mutations. Therefore, the magnetic bead-mannose-binding lectin complex of the present application, the method of enriching microorganisms in respiratory samples using the complex, and the method of enriching microorganisms in respiratory samples using the complex and then performing metagenomic sequencing provide technical references for rapid and accurate diagnosis of respiratory infectious diseases, airway microbiome research, and the transmission and drug resistance monitoring of respiratory pathogens.
[0077] The technical solution provided by the present invention is further described below in conjunction with specific embodiments. The following embodiments are only used to illustrate the present invention and will not limit the protection scope of the present invention.
[0078] Example 1. Construction of MBL magnetic beads
[0079] Dynabeads used in this study TM M-270 Epoxy magnetic beads (NO.14301) were purchased from Thermo Fisher Scientific, USA. MBL protein was purchased from Beijing Biopsies Biotechnology Co., Ltd. According to the manufacturer's instructions, 60 mg of Dynabeads TMAdd 2 mL of dimethylformamide (DMF) to M-270Epoxy to make the final concentration of magnetic beads 2×10 9 / mL. Take 165μL (5mg, 3.3×10 8 ) epoxy resin magnetic beads, placed on the magnetic stand for 4 minutes and discard the supernatant. After resuspending the magnetic beads with 100 μL sodium phosphate buffer (pH = 7.4), add 100 μL 3M ammonium sulfate solution (as a buffer to provide a suitable pH value and salt ion strength for the coupling process between the magnetic beads and the MBL protein) and 100 μL of 1 μg / μL MBL protein solution in sequence, mix thoroughly and place the centrifuge tube in a rotating culture mixer, incubate at 37°C for 24 hours. After incubation, wash 4 times with 1 mL of sterile PBS solution (0.1% skim milk). After washing, add 100 μL sterile PBS solution (0.1% skim milk) to resuspend the magnetic beads and store them in a refrigerator at 4°C for a short time. Figure 1 This is the construction principle of MBL magnetic beads.
[0080] After the MBL magnetic beads were constructed, the coupling effect of MBL protein and magnetic beads was detected using the PierceTM BCA protein detection kit (Thermo Fisher Scientific, USA). 7 ) and the same number of bare magnetic beads, placed on the magnetic stand for 2 minutes, discarded the supernatant and resuspended with 25 μL PBS solution. 25 μL of magnetic bead suspension and different concentrations of BSA protein solution were added to 200 μL BCA protein concentration detection working solution, mixed thoroughly and incubated at 37°C for 30 minutes. After incubation, the absorbance value at 562 nm was detected using a multifunctional microplate reader SpectraMax M5 (Molecular Devices, Sunnyvale, CA, USA). Figure 2 The results of BCA protein quantification method. The MBL protein concentration was calculated by drawing a standard curve to be 98 μg / mL. According to the volume of magnetic bead suspension, 0.5 mg magnetic beads (3.3×10 7 The amount of MBL protein coated with each cell was 2.45 μg.
[0081] Example 2. Determination of the enrichment efficiency of MBL magnetic beads for respiratory pathogenic microorganisms in the presence of host cells by plate coating method
[0082] Staphylococcus aureus (S. aureus), Klebsiella pneumoniae (K. pneumoniae) and Pseudomonas aeruginosa (P. aeruginosa) used in this study were provided by Hebei Medical University. Escherichia coli was preserved by the applicant's laboratory. HEK293T cell line was from the American type culture collection CRL-3216 cell line (American type culture collection, ATCC, CRL-3216). Columbia blood agar medium was purchased from Beijing Solebow Technology Co., Ltd.
[0083] Take 500 μL HEK293T (2×10 5 / mL) cell solution and 500μL bacterial solution (2×10 3 Colony forming units (CFU) / mL) were mixed thoroughly to construct a simulated respiratory infection sample. The concentration of HEK293T cells in the simulated sample was 1×10 5 / mL, the bacterial concentration is 1×10 3 CFU / mL. Add 4 μL of 1M sterile CaCl2 to the simulated sample and mix thoroughly to make Ca 2+ The concentration was 4 mM. 0.5 mg of MBL magnetic beads (3.3 × 10 7 ) or an equal amount of bare magnetic beads, mix thoroughly and place in a rotating culture mixer, incubate at 37°C for 1h. After incubation, wash the magnetic beads 3 times with sterile PBS solution (100μL / 0.5mg magnetic beads) to avoid bacterial liquid remaining on the surface of the magnetic beads. After resuspending the magnetic beads with sterile PBS solution (100μL / plate), transfer the magnetic bead suspension to Columbia blood agar plate and spread it evenly with a coating rod. At the same time, draw 100μL of unenriched sample and spread it evenly on Columbia blood agar plate as a control sample before enrichment. Spread 3 plates for each experimental group at the same time. All plates were placed in a 37°C incubator for static culture for 24h. After the culture was completed, the number of colonies formed in each plate was calculated. The ratio of the average number of colonies formed on Columbia blood agar plates after enrichment and before enrichment was calculated as the enrichment efficiency of MBL magnetic beads for this type of bacteria. Figure 3 Figure 1 shows the culture results of the original sample, MBL magnetic bead enriched sample, and bare magnetic bead enriched sample of Staphylococcus aureus (A), Klebsiella pneumoniae (B), and Pseudomonas aeruginosa (C). 3 CFU / mL bacterial concentration and 1×10 5 Under the host cell background of 100 μg / mL, the enrichment efficiency of MBL magnetic beads for Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa was 85%, 75% and 45% respectively. The enrichment efficiency of MBL magnetic beads for the above three bacteria was significantly higher than that of naked magnetic beads without protein coating.
[0084] Example 3. Combined application of MBL magnetic beads enrichment and airway microbial metagenomic sequencing
[0085] 3.1 Collection of throat swab samples
[0086] After obtaining informed consent, oropharyngeal tissues of 8 healthy volunteers (AH) were scraped with cotton swabs and placed in collection tubes, which were vortexed for 20 seconds to fully mix the pharyngeal swabs.
[0087] 3.2MBL magnetic beads enrichment
[0088] Take 500 μL of throat swab sample into a 1.5 mL centrifuge tube. Add 2 μL of 1 M sterile CaCl2 and mix thoroughly. 2+ The concentration was 4 mM. 1.25 mg of MBL magnetic beads (8.25 × 10 7 ), mix thoroughly and place in a rotary culture mixer for enrichment at 37°C for 1 hour. After enrichment, use 500 μL of 0.1M citrate solution to elute the microorganisms bound to the magnetic beads. Another 500 μL of throat swab sample was drawn into a 1.5 mL centrifuge tube as a control sample before enrichment.
[0089] 3.3 Nucleic acid extraction
[0090] The ZR BashingBead (R2040) used in this study was purchased from Zymo Research, USA. The miniMAG kit was purchased from bioMérieux, France. ZRBashingBead was added to the enriched samples to lyse the bacterial cell wall, and then the miniMAG magnetic beads method was used to extract nucleic acids from the lysed samples.
[0091] 3.4 Metagenomic sequencing library construction
[0092] Illumina library construction kits used in this study Flexible DNA LibraryPrep Kit for Illumina TD504 and TruePrep Index Kit V3 for Illumina (Vazyme#TD203) were purchased from Nanjing Novaseq. According to the manufacturer's instructions, the TD504 library construction kit is based on the transposase principle. First, the DNA in the extracted sample nucleic acid is fragmented, and sequencing adapters are added to the ends of the fragmented DNA. Then, N6 (N6XX) and N8 (N8XX) are used for PCR amplification to complete the construction of the high-throughput sequencing library. The primer sequence information is shown in Table 1. The library was sent to Annoroad Gene Technology (Beijing) Co., Ltd. for Illumina Novaseq sequencing, and the sample target sequencing volume was set to 6G.
[0093] Table 1
[0094]
[0095] Example 4. The improvement effect of MBL magnetic beads enrichment on metagenomic sequencing analysis
[0096] 4.1 Analysis of the proportion of host gene fragments in sequencing data before and after enrichment
[0097] After the sequencing data were returned, Fastp v0.20.1 was used to filter the low-quality sequencing fragments in the data, and the filtered sequencing data were used for subsequent analysis. The microbiome annotation software Kraken v2.1.2 was used to annotate the filtered data with species information and obtain the sequencing reads corresponding to the corresponding species. Figure 4 The data are statistically analyzed for the amount of sequencing data after quality control in samples before (Pre) and after (MBL) enrichment with MBL magnetic beads. The results show that there is no significant difference in the number of high-quality reads retained after quality control of sequencing data before and after enrichment (p = 0.29), so the amount of sequencing data will not introduce obvious bias to the conclusions drawn from subsequent related analyses.
[0098] Figure 5 The ratio of host (A) and microbial (B) fragments in the samples before (Pre) and after (MBL) MBL magnetic bead enrichment. In the sequencing data after enrichment, the ratio of host gene fragments was significantly lower than that before enrichment (p = 0.007), and the ratio of host gene fragments in the sequencing data after enrichment could be reduced by up to 44.45% (interquartile range: 9.82%-33.79%). This result is higher than the effect of two microbial enrichment kits NEBNext (0%) and Molzym MOlYsis (37.12%) on removing host DNA in saliva samples reported in recent literature [see: Maroz, CA, JG Sanders, C. Zuniga, et al., Improving saliva shotgun metagenomics by chemical host DNA depletion. Microbiome, 2018.6 (1): p. 42.]. Fluorescence quantitative PCR was used to detect the glyceraldehyde-3-phosphate dehydrogenase (GADPH) gene level in samples before and after enrichment. The median Ct value of the sample before enrichment was used as the benchmark, and the original Ct values of all samples were converted to GADPH gene levels through the △Ct value. Figure 6 The results of quantitative analysis of GADPH gene in samples before (Pre) and after (MBL) enrichment. The results showed that the level of this gene in samples after MBL magnetic bead enrichment was significantly lower than that before enrichment (p = 5.0 × 10-5 ), the average level of the gene decreased by 99.5% after enrichment.
[0099] at the same time, Figure 5 Results B showed that the proportion of microbial gene fragments that could be matched after enrichment increased significantly compared with the samples before enrichment (p = 0.013), and the proportion of microbial gene fragments that could be matched could be increased by up to 24.56% (interquartile range: 3.32%-16.10%). Therefore, MBL magnetic bead enrichment can significantly increase the proportion of airway microbial gene fragments in metagenomic sequencing data.
[0100] 4.2 Analysis of microbial composition in sequencing data before and after enrichment
[0101] After removing host gene fragments and microbial gene fragments with an abundance of less than 1% at the corresponding species classification level, the Chao 1 index reflecting the microbial richness in each sample was calculated using the Vegan package v2.6-4 in R v4.2.1. The larger the Chao 1 index, the higher the microbial richness. Figure 7 The Chao1 index of the microbiome between samples before (Pre) and after (MBL) enrichment was statistically significant. The Chao1 index of samples after MBL magnetic beads enrichment was significantly higher than that of samples before enrichment (p = 0.003), proving that MBL magnetic beads enrichment can significantly increase the richness of microorganisms in samples.
[0102] The Bray-Curtis distance, a β-diversity index reflecting species composition differences between samples, was calculated. Principal coordinate analysis was performed based on the Bray-Curtis distance. Permutational multivariate analysis of variance (PERMANOVA) was used to test the differences in microbial composition between samples before and after enrichment. Figure 8 The results of principal coordinate analysis of the microbiome of samples from different volunteers before (Pre) and after (MBL) enrichment. The results of one-way PERMANOVA showed that the β diversity difference between the MBL magnetic bead enrichment group samples and the control samples was small (R 2 =0.15, p=0.047). To further analyze the influence of individual composition differences and enrichment process on microbial composition, the variable of volunteer individuals was introduced into the multivariate PERMANOVA analysis. The results of multivariate PERMANOVA showed that individual factors accounted for about 56% of the total variation in the microbial composition between samples (R 2 =0.56, p=0.017), while the variation caused by the enrichment process accounted for about 15% of the total variation (R 2 =0.15, p=0.012), so the differences in microbial composition between enriched samples were mainly manifested as original differences between individuals.
[0103] Fig. 9is the Bray-Curtis distance index between different samples of the same volunteer and samples of different volunteers. The independent sample Student's t-test was used to compare the differences in the Bray-Curtis index within and between samples. Fig. 9 As shown, the average Bray-Curtis distance between samples from the same volunteer before and after enrichment was significantly lower than the average Bray-Curtis distance between samples from different volunteers after enrichment (p = 0.01), indicating that the enrichment process will not have a significant impact on the differences in microbial composition between different samples.
[0104] 4.3 Analysis of detection of microbial functional genes in sequencing data before and after enrichment
[0105] The software Abricate v0.8 was used to compare the sequencing data after quality control with the reference database to obtain the information of drug resistance genes and virulence genes carried by the microorganisms in the samples. Among them, the drug resistance gene reference database uses the Comprehensive Antibiotic Resistance Database (CARD), and the virulence gene database uses the Virulence Factor Database (VFDB, http: / / www.mgc.ac.cn / VFs / ).
[0106] Fig.10 Comparison of the number of drug-resistant genes in samples before (Pre) and after (MBL) enrichment (A), the detection of all drug-resistant genes in samples before (Pre) and after (MBL) enrichment (B), and the statistical results of drug-resistant genes with significantly increased numbers after enrichment (C). Fig.10 A shows that there is no significant difference in the number of sample reads after quality control ( Figure 4 ), the number of drug-resistant genes detected by metagenomic sequencing after MBL magnetic bead enrichment was significantly higher than that before enrichment (p = 0.002). Among all 324 drug-resistant genes detected, the average number of genes of 299 drug-resistant genes (92%) in the enriched samples was higher than that in the pre-enriched samples, of which 193 drug-resistant genes (60%) were only detected in the enriched samples ( Fig.10 B). Fig.10C showed that the number of 63 drug-resistant genes increased significantly after enrichment (p<0.05), among which the number of aminoglycoside phosphotransferase gene aph(3')-Ia (p=0.03), multidrug transporter gene emrD (p=0.007), MLSB resistance gene ermF (p=0.047), AcrA-AcrB-TolC multidrug efflux complex gene acrB (p=0.04), MdtABC-TolC efflux complex gene mdtB (p=0.005), MdtEF-TolC efflux complex gene mdtF (p=0.03) and tetracycline efflux pump gene tetC (p=0.03) in all enriched samples increased compared with that before enrichment. Fig.11 Comparison of the number of bacterial virulence genes in samples before (Pre) and after (MBL) enrichment (A), statistics of the number of all virulence genes detected (B), and statistics of virulence genes with increased detection numbers in all enriched samples (C). Under the premise that there is no significant difference in the number of sample reads after quality control, Fig.11 A shows that the number of bacterial virulence genes detected by metagenomic sequencing after MBL magnetic bead enrichment was significantly higher than that before enrichment (p = 0.008). Among all 453 virulence genes detected, the average number of genes detected in 403 virulence genes (89%) in the enriched samples increased compared with that before enrichment, of which 172 drug resistance genes (38%) were only detected in the enriched samples ( Fig.11 B). Fig.11 C shows that among the 68 virulence genes whose numbers increased significantly after enrichment, the bacterial chemotaxis protein genes cheA (p=0.048) and cheY (p=0.002), the Enterobacterial iron outer membrane transporter gene fepA (p=0.008), the Escherichia coli type I fimbrial synthesis-related gene fimD (p=0.009), the flagellar biosynthesis protein gene flhA (p=0.002), the flagellar motor switch protein gene fliM (p=0.0008) and the Escherichia coli common fimbrial synthesis-related gene yagX / ecpC (p=0.03) increased in number in all enriched samples compared with before enrichment.
[0107] After obtaining the reference genomes of Klebsiella pneumoniae (NC_016845.1) and Bacteroides fragilis (NZ_CP069563.1) from the NCBI website (https: / / www.ncbi.nlm.nih.gov / ), Bowtie2 v2.2.5 was used to align the sequencing data of each sample with the reference genomes of the two common opportunistic pathogens mentioned above. The alignment results were used to calculate the sequencing depth of each site of the reference genome using Samtools v1.3.1. Fig.12The genome coverage statistics of Klebsiella pneumoniae (A) and Bacteroides fragilis (B) before enrichment (Pre) and after enrichment (MBL) were shown. Klebsiella pneumoniae (p = 0.008) and Bacteroides fragilis (p = 7.6 × 10 -4 ) After enrichment, the coverage of genomic sites with a sequencing depth greater than 10 was significantly higher than that before enrichment. Therefore, the above results show that sequencing after enrichment can increase the coverage of genomic sites of extremely low-abundance microorganisms in throat swab samples, which is helpful for the analysis of related gene functions and mutations.
[0108] 4.4 Analysis of the effect of metagenomic sequencing data assembly before and after enrichment
[0109] The prokaryotic genome assembly software Unicycler v0.5.0 was used to assemble the sequencing data after quality control. The assembled genome sequence was annotated with species using Ncbi-blast-2.12.0+, and the reference database was the Nucleotide Sequence Database of the National Center for Biotechnology Information (NCBI). The microbial genome coverage was calculated by calculating the percentage of the total length of the metagenome assembled genome (MAG) in the sample to the length of the microbial reference genome.
[0110] After all samples were assembled and aligned, the types and numbers of microorganisms corresponding to MAGs (159) with a reference genome length greater than 25 Kbp were statistically mapped at the microbial species level. Fig.13 =The number of species-level MAGs (alignment length >= 25Kbp) in the samples before and after enrichment. All MAGs were aligned to 20 microbial genomes. A total of nine microorganisms had a higher total number of MAGs assembled after enrichment than before enrichment. Among these nine microorganisms, MAGs of six microorganisms were only detected in the enriched data, including Neisseria flavescens, Campylobacter concisus, Haemophilus influenzae, and three Capnocytophaga sp.FDAARGOS_737, Capnocytophaga gingivalis, and Capnocytophaga leadbetteri.
[0111] The prokaryotic gene annotation software Prokka v1.13 was used to annotate the above-mentioned microbial MAG genomes. The ratio of the MAG length of the common microorganisms between samples before and after enrichment to the average genome length of each microorganism (i.e., coverage) and the number of genes obtained after the MAG genome annotation were counted. Fig.14 The statistics of the common microbial genome coverage after sample assembly before and after enrichment. The genome coverage of the four microorganisms, Bacteroides sp.M10, Neisseria subflava, Prevotella jejuni, and Rothia mucilaginosa, after enrichment increased by 0.09%, 3.63%, 5.07%, and 1.28%, respectively, compared with the samples before enrichment.
[0112] Fig.15 The statistics of the number of genes assembled and annotated by the above six common microorganisms before and after enrichment. Corresponding to the coverage results, the number of genes assembled and annotated by Neisseria subflava, Prevotella jejuni and Rothia mucilaginosa after enrichment increased by 77, 159 and 15 respectively compared with those before enrichment. Among them, the corresponding MAGs of Neisseria subflava were successfully assembled in the samples of three volunteers before and after enrichment. The number of genes assembled and annotated by this bacterium after enrichment (average = 156) increased significantly compared with that before enrichment (average = 79) (p = 0.03). Compared with before enrichment, the mexB gene encoding multidrug resistance protein and the rluF gene encoding 23S rRNA pseudouridine synthase in the genome of this bacterium after enrichment were annotated in the MAGs assembled by two volunteers. Obtaining the above gene sequence information after enrichment is helpful for functional genomics research.
[0113] The series of detailed descriptions listed above are only specific descriptions of feasible implementation methods of the present invention. They are not intended to limit the scope of protection of the present invention. Those skilled in the art can design many other modifications and implementation methods, which will fall within the scope and spirit of the principles disclosed in this application. More specifically, within the scope of the disclosure, drawings and claims of this application, various modifications and improvements can be made to the components and / or layout of the subject combination layout. In addition to the modifications and improvements made to the components and / or layout, other uses will also be obvious to those skilled in the art.
Claims
1. A magnetic bead-mannose binding lectin complex, wherein: The magnetic beads are linked to the mannose-binding lectin via the -(CH2)3CHOHCH2NH- group.
2. The magnetic bead-mannose binding lectin complex according to claim 1, wherein The magnetic beads are epoxy resin magnetic beads; Preferably, the magnetic beads are Dynabeads TM M-270Epoxy epoxy resin magnetic beads.
3. A method for constructing a magnetic bead-mannose binding lectin complex, wherein: The magnetic beads were mixed with mannose-binding lectin and incubated.
4. The method according to claim 3, wherein: Add ammonium sulfate solution and mannose-binding lectin protein solution to the magnetic bead suspension, mix, and incubate; Preferably, the concentration of the ammonium sulfate solution is 1-3 mol / L; Preferably, the magnetic beads and mannose binding lectin are mixed at a rate of (2-5)×10 8 Mixed at a ratio of magnetic beads / 100 μg mannose-binding lectin; More preferably, the magnetic beads and the mannose-binding lectin are mixed at a rate of (3-4)×10 8 Mixed at a ratio of magnetic beads / 100 μg mannose-binding lectin; And / or, the incubation is at 30-40° C. for 18-30 h; Preferably, the incubation is at 35-38°C for 22-26 hours; More preferably, the incubation is incubation in a rotary culture mixer; And / or, the magnetic beads are epoxy resin magnetic beads; Preferably, the magnetic beads are Dynabeads TM M-270Epoxy epoxy resin magnetic beads.
5. A method for enriching microorganisms in a respiratory sample, comprising the following steps: 1) mixing a respiratory sample with the magnetic bead-mannose binding lectin complex of claim 1 or 2, and incubating the mixture; 2) eluting the microorganisms enriched on the surface of the magnetic bead-mannose binding lectin complex to obtain enriched respiratory samples.
6. The method according to claim 5, wherein: The respiratory sample is a freshly collected throat swab.
7. The method according to claim 5 or 6, wherein: The incubation is performed at 30 to 40° C. for 0.5 to 2 h; Preferably, the incubation is at 35-38°C for 0.7-1.5h; The incubation is carried out in a rotary culture mixer; And / or, the elution process is: first use sterile PBS buffer to wash the magnetic bead-mannose binding lectin complex, wash 2 to 5 times, and then use 0.05 to 0.2 M citrate solution to wash the magnetic bead-mannose binding lectin complex.
8. A method for performing metagenomic sequencing on a respiratory sample, comprising the following steps: 1) mixing a respiratory sample with the magnetic bead-mannose binding lectin complex of claim 1 or 2, and incubating the mixture; 2) eluting the microorganisms enriched on the surface of the magnetic bead-mannose binding lectin complex to obtain enriched respiratory samples; 3) Extracting DNA from enriched respiratory samples; 4) Construct an Illumina sequencing library and perform metagenomic sequencing.
9. The method according to claim 8, wherein: The respiratory sample was a freshly collected throat swab.
10. The method according to claim 8 or 9, wherein: The process of extracting DNA from the enriched respiratory sample is: firstly, ZR BashingBead is added to the enriched respiratory sample to lyse the bacterial cell wall, and then the DNA is extracted from the lysed sample using the miniMAG magnetic bead method; And / or, construct Illumina sequencing libraries using TruePrep Flexible DNA Library Prep Kit for Illumina.
Citation Information
Patent Citations
Engineered opsonin for pathogen detection and treatment
CN102947341A
Lectin-magnetic carrier coupled complex used for separating glycosylated exosomes in clinical samples
CN111253491A
Preparation method of CD45 antibody magnetic bead
CN115308404A
